Cargando…

Vaccines for the 21st Century : a Tool for Decisionmaking.

Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Stratton, Kathleen R.
Otros Autores: Durch, Jane S., Lawrence, Robert S.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington : National Academies Press, 2000.
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 EBOOKCENTRAL_ocn923268352
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 151010s2000 dcu ob 001 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d OCLCQ  |d S4S  |d COO  |d XFH  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d ZCU  |d OCLCQ  |d OCLCO  |d STF  |d OCLCF  |d OCLCO  |d EZ9  |d ICG  |d OCLCQ  |d OCLCA  |d LVT  |d OCLCA  |d TKN  |d DKC  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
019 |a 697777432  |a 1229771984 
020 |a 9780309564434 
020 |a 0309564433 
020 |a 9780309056465 
020 |a 0309056462 
029 1 |a DEBBG  |b BV044107785 
029 1 |a AU@  |b 000068478794 
035 |a (OCoLC)923268352  |z (OCoLC)697777432  |z (OCoLC)1229771984 
037 |b 00017961 
043 |a n-us--- 
050 4 |a RA638.I556 2000eb 
082 0 4 |a 615.372 
049 |a UAMI 
100 1 |a Stratton, Kathleen R. 
245 1 0 |a Vaccines for the 21st Century :  |b a Tool for Decisionmaking. 
260 |a Washington :  |b National Academies Press,  |c 2000. 
300 |a 1 online resource (476 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a Vaccines for the 21st Century -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- THE ANALYTIC FRAMEWORK -- ETHICAL ISSUES -- RESULTS -- OBSERVATIONS -- 1 Introduction -- CONSIDERATIONS RELATED TO THE MODEL AND THE STUDY -- ORGANIZATION OF THE REPORT -- Charge to the Committee -- Committee Membership and Meetings -- Organization of the Report -- 2 Progress in Vaccine Development -- PRIORITIES OF THE IOM COMMITTEE IN 1985 -- LITIGATION AS A BARRIER TO VACCINE DEVELOPMENT -- Immunization of Pregnant Women -- A CASE STUDY OF SUCCESS 
505 8 |a Disease BurdenPolio Vaccine Development -- Advantages of Evolving Vaccine Strategies -- ADVANCES IN BIOTECHNOLOGY AND MOLECULAR IMMUNOLOGY AND NEW OPPORTUNITIES FOR VACCINES -- Fundamental Understanding of Helper T Cells for Antibody Versus CMI Responses, and for Cytotoxicity -- Major Advances in Mucosal Immunity -- Mucosal Immune System Organization -- Molecular Aspects of Virulence and Design of Recombinant Protein Vaccines -- Novel Vaccine Delivery Systems -- Recent Advances in Development of Novel Adjuvants 
505 8 |a Scientific Rationale for Vaccines against Autoimmune DiseasesImmune Tolerance Induction -- Immune Deviation -- Receptor-Centered Regulation -- Targeting Cytokines or Their Receptors -- Viral Vectors in Autoimmune Therapy -- Preventive Vaccines for Autoimmune Diseases -- 3 Considerations of Candidate Vaccines -- EXCLUSION CRITERIA -- Insufficient Basic Science Information -- Existence of Appropriate Prevention Interventions -- International Burden of Disease -- ADDITIONAL CONSIDERATIONS FOR INCLUSION -- Therapeutic Vaccines -- Programmatic Considerations 
505 8 |a Delivery of Vaccines to ChildrenDelivery of Vaccines to Adults -- Delivery of Vaccines to Pregnant Women -- 4 Overview of Analytic Approach and Results -- A COST-EFFECTIVENESS APPROACH -- Reasons for Using Cost-Effectiveness Analysis -- Limits of Cost-Effectiveness Analysis -- Ethical Issues -- Analytic Perspectives -- Time Horizon and Discounting -- MODEL OVERVIEW -- Health Benefits: The Denominator -- Quality Adjustments: Weighting -- Morbidity Scenarios -- Quality Adjustments for Average Population Health States -- Disease Incidence and Death Rates 
505 8 |a Time IntervalsQALYs Gained with Vaccine Use -- Costs: The Numerator -- Cost of Research and Development -- Cost of Vaccine Use -- Health Care Costs -- Vaccine Efficacy and Utilization -- Cost-Effectiveness Ratios -- Exclusions from the Analysis -- EXAMPLES: HYPOTHETICAL VACCINE X -- Target Population -- Program Considerations -- Disease Severity -- Discounting -- An Idealized Scenario -- Summary -- RESULTS -- Challenges -- 5 Review of the Analytic Model -- UNIT OF ANALYSIS -- IMPLEMENTING THE ANALYSIS -- Basic Model -- Performing the Analysis 
500 |a ""Calculation of health benefits"" 
520 8 |a Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis. 
504 |a Includes bibliographical references and index. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Immunization  |x Research  |z United States  |x Planning. 
650 0 |a Vaccines  |x Research  |z United States  |x Planning. 
650 0 |a Mathematical models. 
650 0 |a Research. 
650 0 |a Vaccines. 
650 0 |a Economics. 
650 0 |a Science. 
650 0 |a Physical sciences. 
650 0 |a Medical care. 
650 0 |a Biological products. 
650 2 |a Models, Theoretical 
650 2 |a Research 
650 2 |a Vaccines 
650 2 |a Economics, Pharmaceutical 
650 2 |a Biological Factors 
650 2 |a Economics 
650 2 |a Science 
650 2 |a Investigative Techniques 
650 2 |a Health Care Economics and Organizations 
650 2 |a Natural Science Disciplines 
650 2 |a Complex Mixtures 
650 2 |a Analytical, Diagnostic and Therapeutic Techniques and Equipment 
650 2 |a Delivery of Health Care 
650 2 |a Chemicals and Drugs 
650 2 |a Disciplines and Occupations 
650 2 |a Patient Care 
650 6 |a Immunisation  |x Recherche  |z États-Unis  |x Planification. 
650 6 |a Vaccins  |x Recherche  |z États-Unis  |x Planification. 
650 6 |a Modèles mathématiques. 
650 6 |a Recherche. 
650 6 |a Vaccins. 
650 6 |a Pharmacoéconomie. 
650 6 |a Produits biologiques. 
650 6 |a Économie politique. 
650 6 |a Sciences. 
650 6 |a Sciences physiques. 
650 6 |a Prestation de soins. 
650 6 |a Soins médicaux. 
650 7 |a mathematical models.  |2 aat 
650 7 |a research (function)  |2 aat 
650 7 |a economics.  |2 aat 
650 7 |a sciences (philosophy)  |2 aat 
650 7 |a physical sciences.  |2 aat 
650 7 |a science (modern discipline)  |2 aat 
650 7 |a Vaccines  |2 fast 
650 7 |a Science  |2 fast 
650 7 |a Research  |2 fast 
650 7 |a Physical sciences  |2 fast 
650 7 |a Medical care  |2 fast 
650 7 |a Mathematical models  |2 fast 
650 7 |a Economics  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
700 1 |a Durch, Jane S. 
700 1 |a Lawrence, Robert S. 
758 |i has work:  |a Vaccines for the 21st century (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGqf6krqKT9BvP6pJQX68C  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Stratton, Kathleen R.  |t Vaccines for the 21st Century : A Tool for Decisionmaking.  |d Washington : National Academies Press, ©1900  |z 9780309056465 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3377114  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3377114 
994 |a 92  |b IZTAP